Ibrutinib Has Time-dependent On- and Off-target Effects on Plasma Biomarkers and Immune Cells in Chronic Lymphocytic Leukemia

Ibrutinib is a covalently binding inhibitor of the B-cell receptor signaling-mediator Bruton’s tyrosine kinase (BTK) with great efficacy in chronic lymphocytic leukemia (CLL). Common side effects like atrial fibrillation (AF), bleeding and infections might be caused by ibrutinib’s inhibition of othe...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Hemasphere
Main Authors: Mulder, Tom A., Peña-Pérez, Lucía, Berglöf, Anna, Meinke, Stephan, Estupiñán, H. Yesid, Heimersson, Kia, Zain, Rula, Månsson, Robert, Smith, C. I. Edvard, Palma, Marzia
Format: Artigo
Sprog:Inglês
Udgivet: Lippincott Williams & Wilkins 2021
Fag:
Article
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC8078281/
https://ncbi.nlm.nih.gov/pubmed/33912812
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/HS9.0000000000000564
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker